Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Chronic Heart Failure

Free Subscription 25.03.2019 1 Am J Cardiol 1 Basic Res Cardiol 1 Circ Arrhythm Electrophysiol 1 Circ Heart Fail 5 Circulation 19 Eur J Heart Fail 3 Heart 1 Hypertension 1 Int J Cardiol 4 J Am Coll Cardiol 2 J Card Fail 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Cardiol

1. MEFFORD MT, Sephel A, Van Dyke MK, Chen L, et al
   Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).
   Am J Cardiol. 2019 Feb 23. pii: S0002-9149(19)30229.
   PubMed     Text format     Abstract available
   
   

   
   Basic Res Cardiol

2. BACMEISTER L, Schwarzl M, Warnke S, Stoffers B, et al
   Inflammation and fibrosis in murine models of heart failure.
   Basic Res Cardiol. 2019;114:19.
   PubMed     Text format     Abstract available
   
   

   
   Circ Arrhythm Electrophysiol

3. PACKER M
   What Have We Learned From Randomized Controlled Trials of Catheter Ablation for Atrial Fibrillation in Patients With Chronic Heart Failure?
   Circ Arrhythm Electrophysiol. 2019;12:e007222.
   PubMed     Text format    
   
   

   
   Circ Heart Fail

4. 
   Correction to: Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
   Circ Heart Fail. 2019;12:e000035.
   PubMed     Text format    
   
   

   
   Circulation

5. VERMA S, McMurray JJV
   The Serendipitous Story of SGLT2 Inhibitors in Heart Failure: New Insights from DECLARE-TIMI 58.
   Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040514.
   PubMed     Text format     Abstract available
   
   
6. KATO ET, Silverman MG, Mosenzon O, Zelniker TA, et al
   Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.
   Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.040130.
   PubMed     Text format     Abstract available
   
   
7. FIGTREE GA, Radholm K, Barrett TD, Perkovic V, et al
   Effects of Canagliflozin on Heart Failure Outcomes Associated with Preserved and Reduced Ejection Fraction in Type 2 Diabetes: Results from the CANVAS Program.
   Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040057.
   PubMed     Text format     Abstract available
   
   
8. BOTS SH, den Ruijter HM
   Recommended Heart Failure Medications and Adverse Drug Reactions in Women.
   Circulation. 2019;139:1469-1471.
   PubMed     Text format    
   
   
9. NIELSEN R, Moller N, Gormsen LC, Tolbod LP, et al
   Cardiovascular Effects of Treatment with the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients.
   Circulation. 2019 Mar 19. doi: 10.1161/CIRCULATIONAHA.118.036459.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Heart Fail

10. RICHARDS AM, Pemberton C, Yandle T
    How does neprilysin inhibition in heart failure work?
    Eur J Heart Fail. 2019 Mar 18. doi: 10.1002/ejhf.1454.
    PubMed     Text format    
    
    
11. GHAFOURIAN K, Chang HC, Ardehali H
    Intravenous iron therapy in heart failure: a different perspective.
    Eur J Heart Fail. 2019 Mar 18. doi: 10.1002/ejhf.1434.
    PubMed     Text format    
    
    
12. COATS AJS, Seferovic PM
    News from the American Heart Association: more on sodium-glucose co-transporter 2 inhibitors, diabetes and heart failure.
    Eur J Heart Fail. 2019;21:261-263.
    PubMed     Text format    
    
    
13. METRA M
    Figures of the Heart Failure Association: Andrew J. Stewart Coats, President-Elect, 2018-2020.
    Eur J Heart Fail. 2019;21:269-271.
    PubMed     Text format    
    
    
14. PAPADAKI A, Martinez-Gonzalez MA, Alonso-Gomez A, Rekondo J, et al
    Mediterranean diet and risk of heart failure: results from the PREDIMED randomized controlled trial. Eur J Heart Fail 2017;19:1179-1185. doi: 10.1002/ejhf.750.
    Eur J Heart Fail. 2019;21:389-391.
    PubMed     Text format    
    
    
15. COATS AJS
    Figures of the Heart Failure Association: Petar M. Seferovic, President, 2018-2020.
    Eur J Heart Fail. 2019;21:266-268.
    PubMed     Text format    
    
    
16. AHMAD T, Freeman JV, Asselbergs FW
    Can advanced analytics fix modern medicine's problem of uncertainty, imprecision, and inaccuracy?
    Eur J Heart Fail. 2019;21:86-89.
    PubMed     Text format    
    
    
17. MEHRA MR
    Evolving disruption in left ventricular assist systems: forgiving but not yet forgettable.
    Eur J Heart Fail. 2019;21:98-100.
    PubMed     Text format    
    
    
18. LUND LH
    Improving long-term outcomes with left ventricular assist devices-referral, selection, experience, and technology.
    Eur J Heart Fail. 2019;21:101-102.
    PubMed     Text format    
    
    
19. FERREIRA JP, Zannad F
    Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?
    Eur J Heart Fail. 2019;21:71-73.
    PubMed     Text format    
    
    
20. GORI M, Redfield MM, Calabrese A, Canova P, et al
    Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study.
    Eur J Heart Fail. 2018;20:1540-1548.
    PubMed     Text format     Abstract available
    
    
21. SANDERS NA, Supiano MA, Lewis EF, Liu J, et al
    The frailty syndrome and outcomes in the TOPCAT trial.
    Eur J Heart Fail. 2018;20:1570-1577.
    PubMed     Text format     Abstract available
    
    
22. AL-SAAIDI RA, Rasmussen TB, Birkler RID, Palmfeldt J, et al
    The clinical outcome of LMNA missense mutations can be associated with the amount of mutated protein in the nuclear envelope.
    Eur J Heart Fail. 2018;20:1404-1412.
    PubMed     Text format     Abstract available
    
    
23. LINDE CM, Normand C, Bogale N, Auricchio A, et al
    Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II.
    Eur J Heart Fail. 2018;20:1457-1468.
    PubMed     Text format     Abstract available
    
    
24. TRULLAS JC, Formiga F, Manzano L
    The use of thiazide and thiazide-like diuretics in heart failure with congestion.
    Eur J Heart Fail. 2019 Mar 20. doi: 10.1002/ejhf.1455.
    PubMed     Text format    
    
    
25. BAVENDIEK U, Berliner D, Davila LA, Schwab J, et al
    Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled study.
    Eur J Heart Fail. 2019 Mar 20. doi: 10.1002/ejhf.1452.
    PubMed     Text format     Abstract available
    
    
26. MCMURRAY JJV, DeMets DL, Inzucchi SE, Kober L, et al
    A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
    Eur J Heart Fail. 2019 Mar 21. doi: 10.1002/ejhf.1432.
    PubMed     Text format     Abstract available
    
    
27. TEMPORELLI PL, Tilz RR, Arbelo E, Dagres N, et al
    Clinical characteristics of heart failure patients undergoing atrial fibrillation ablation today in Europe. Data from the atrial fibrillation registries of the European Society of Cardiology and the European Heart Rhythm Association.
    Eur J Heart Fail. 2019 Mar 21. doi: 10.1002/ejhf.1458.
    PubMed     Text format    
    
    
28. MULLENS W, Damman K
    Reply to letters on "The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology".
    Eur J Heart Fail. 2019 Mar 22. doi: 10.1002/ejhf.1462.
    PubMed     Text format    
    
    

    
    Heart

29. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.
    PubMed     Text format    
    
    
30. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Text format     Abstract available
    
    
31. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Text format     Abstract available
    
    

    
    Hypertension

32. FLEENOR BS, Ouyang A, Olver TD, Hiemstra JA, et al
    Saxagliptin Prevents Increased Coronary Vascular Stiffness in Aortic-Banded Mini Swine.
    Hypertension. 2018;72:466-475.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cardiol

33. SCHWIER NC
    Betaeta-blocker therapy in cocaine-associated heart failure: Attempting to mitigate the risk.
    Int J Cardiol. 2019;283:135.
    PubMed     Text format    
    
    

    
    J Am Coll Cardiol

34. SHAH RV, Das S, Lewis GD
    Circulating MicroRNAs: New Avenues for Heart Failure Classification?
    J Am Coll Cardiol. 2019;73:1314-1316.
    PubMed     Text format    
    
    
35. WONG LL, Zou R, Zhou L, Lim JY, et al
    Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.
    J Am Coll Cardiol. 2019;73:1300-1313.
    PubMed     Text format     Abstract available
    
    
36. ANAND IS
    What Explains the Benefits of ARNI Therapy in Heart Failure?
    J Am Coll Cardiol. 2019;73:1285-1287.
    PubMed     Text format    
    
    
37. ARNOLD SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, et al
    Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    J Am Coll Cardiol. 2019 Mar 4. pii: S0735-1097(19)30505.
    PubMed     Text format     Abstract available
    
    

    
    J Card Fail

38. ABU-SALEH N, Aronson D, Khamaisi M, Khoury E, et al
    Increased intra-abdominal pressure induces acute kidney injury in experimental model of congestive heart failure.
    J Card Fail. 2019 Mar 14. pii: S1071-9164(18)30330.
    PubMed     Text format     Abstract available
    
    
39. TSUTSUI H
    Heart Failure Practice in Japan: Successful at Present, but Challenging in the Future.
    J Card Fail. 2019;25:145-146.
    PubMed     Text format    
    
    

    
    PLoS One

40. OYENUGA AO, Couper D, Matsushita K, Boerwinkle E, et al
    Association of monocyte myeloperoxidase with incident cardiovascular disease: The Atherosclerosis Risk in Communities Study.
    PLoS One. 2018;13:e0205310.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: